DIVI S LABORATORIES Stock Context for AI Screening

DIVI S LABORATORIES LTD is a large-cap stock in Healthcare. This page summarizes key screening signals for DIVI S LABORATORIES, including recent returns, momentum indicators, valuation ratios, liquidity, and growth metrics. Gimli uses this context to help users ask natural-language stock screening questions across Indian equities.

Open interactive DIVISLAB stock page

Price

₹6,755.00

1W return

+3.20%

1M return

+3.59%

3M return

+14.84%

6M return

+2.34%

1Y return

-2.64%

Market cap

₹179,324.04 cr

69.83

10.70

ROE

+16.19%

ROCE

+15.70%

RSI

53.81

Turnover

₹241.92 cr

Why it can matter in screens

Momentum: DIVISLAB is above 50DMA, above 200DMA; RSI is 53.81.
Returns: 1D -0.24%, 1W +3.20%, 1M +3.59%, 3M +14.84%, 1Y -2.64%.
Trend levels: 52W high ₹6,983.50, 52W low ₹5,689.50, off high -3.27%.
Liquidity: latest turnover is ₹241.92 cr; volume vs 20D is +1.07%.
Valuation/profitability: PE 69.83, PB 10.70, ROE +16.19%, ROCE +15.70%.
Growth: 3Y sales CAGR +11.27%, 3Y profit CAGR +12.08%.

Financials and Ownership

Quarterly income statement

Period	Revenue	EBITDA	PAT	EPS
2026-03-31	2,831.00 cr	1,089.00 cr	751.00 cr	28.31
2025-12-31	2,604.00 cr	904.00 cr	583.00 cr	21.98
2025-09-30	2,860.00 cr	1,033.00 cr	689.00 cr	25.97
2025-06-30	2,410.00 cr	848.00 cr	545.00 cr	20.49
2025-03-31	2,585.00 cr	972.00 cr	662.00 cr	24.93
2024-12-31	2,319.00 cr	825.00 cr	589.00 cr	22.20
2024-09-30	2,338.00 cr	822.00 cr	510.00 cr	19.20
2024-06-30	2,118.00 cr	701.00 cr	430.00 cr	16.20

Annual income statement

Year	Revenue	EBITDA	PAT	EPS
2026-03-31	10,560.00 cr	3,874.00 cr	2,568.00 cr	96.75
2025-03-31	9,360.00 cr	3,320.00 cr	2,191.00 cr	82.53
2024-03-31	7,796.00 cr	2,544.00 cr	1,600.00 cr	60.27
2023-03-31	7,665.00 cr	2,712.00 cr	1,824.00 cr	68.69
2022-03-31	8,991.08 cr	3,995.38 cr	2,948.54 cr	111.07

Balance sheet

Period	Assets	Cash	Debt	Equity
2026-03-31	20,033.00 cr	128.00 cr	7.00 cr	16,761.00 cr
2025-03-31	16,932.00 cr	415.00 cr	4.00 cr	14,969.00 cr
2024-03-31	15,470.00 cr	363.00 cr	3.00 cr	13,571.00 cr
2023-03-31	14,439.00 cr	170.00 cr	4.00 cr	12,767.00 cr
2022-03-31	13,374.71 cr	1,214.76 cr	3.69 cr	11,728.18 cr

Cash flow

Period	OCF	FCF	Cash change
2026-03-31	2,738.00 cr	218.00 cr	n/a
2025-03-31	1,653.00 cr	215.00 cr	n/a
2024-03-31	1,261.00 cr	258.00 cr	n/a
2023-03-31	2,459.00 cr	1,986.00 cr	n/a
2022-03-31	1,911.80 cr	1,198.60 cr	n/a

Shareholding Trend

Period	Promoter	FII/FPI	DII	MF	Retail	Pledge
2026-03-31	+51.88%	+20.29%	+19.22%	+13.42%	+8.60%	+0.00%
2025-12-31	+51.88%	+20.08%	+19.28%	+13.73%	+8.76%	+0.00%
2025-09-30	+51.89%	+19.39%	+19.76%	+13.99%	+8.96%	+0.00%
2025-06-30	+51.89%	+19.74%	+19.05%	+13.31%	+9.32%	+0.00%
2025-03-31	+51.89%	+18.01%	+20.71%	+12.83%	+9.39%	+0.00%

Industry Peers

Symbol	Name	Mcap	PE	ROE	1Y
SUNPHARMA	SUN PHARMACEUTICAL IND L	453,042.43 cr	39.400236	+14.71%	+12.90%
TORNTPHARM	TORRENT PHARMACEUTICALS L	164,701.07 cr	76.144739	+17.18%	+46.47%
APOLLOHOSP	APOLLO HOSPITALS ENTER. L	125,861.94 cr	64.267738	+21.03%	+15.71%
CIPLA	CIPLA LTD	115,660.88 cr	29.801362	+11.79%	-3.80%
ZYDUSLIFE	ZYDUS LIFESCIENCES LTD	115,515.66 cr	23.036787	+17.93%	+16.76%
LUPIN	LUPIN LIMITED	112,429.39 cr	21.054508	+26.83%	+27.93%
DRREDDY	DR. REDDY S LABORATORIES	112,317.04 cr	26.207396	+11.94%	+5.08%
MAXHEALTH	MAX HEALTHCARE INS LTD	105,577.49 cr	73.195199	+14.33%	-16.28%

Try these prompts

Analyze DIVI S LABORATORIES with valuation, momentum and industry peers
Compare DIVISLAB with other Healthcare stocks
Show large-cap stocks in Healthcare above 50DMA with positive 1M return
Find Healthcare stocks with improving momentum and reasonable valuation

Related screen ideas

Data snapshot: 2026-07-08. Not investment advice.